Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,750 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for 2025-26
Regulatory Filings Classification · 91% confidence The document is titled “Annual Secretarial Compliance Report for the year ended 31-Mar-26” and is issued under Regulation 24A of SEBI (LODR) Regulations. It is a compliance certificate by a practicing company secretary covering statutory and listing compliances, not a financial statement (10-K/IR) or an audit of financials, nor an announcement of a report’s publication. It constitutes a general regulatory filing/certificate under SEBI rules. Thus, it falls into the “Regulatory Filings” (RNS) category.
2026-05-23 English
Audio Recording of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2026
Regulatory Filings Classification · 90% confidence The document is a stock exchange disclosure letter informing that the audio recording of the analysts/investors conference call on audited financial results has been posted on the company website. It contains no financial data itself and is simply a regulatory announcement of where to access the call recording. It does not include the transcript or actual earnings figures, so it does not qualify as a Call Transcript (CT) or Earnings Release (ER). This is a general regulatory announcement and thus falls under the fallback category Regulatory Filings (RNS).
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a short letter sent to stock exchanges under SEBI Listing Regulations announcing that the audio recording of the conference call on the audited financial results has been placed on the company’s website with a link. It is not the transcript itself nor the actual financial results report, but a regulatory disclosure notice. This does not fit into specific report categories (10-K, IR, CT, etc.) and is a general regulatory announcement, so it falls under Regulatory Filings (RNS).
2026-05-22 English
Dividend Updates
Audit Report / Information Classification · 90% confidence The document is a statutory SEBI Listing Regulation disclosure of the audited financial results (standalone and consolidated) for the year and quarter ended March 31, 2026, and includes the full Independent Auditor’s Report. It is not merely a dividend notice, earnings highlights, or a proxy statement, nor does it represent the company’s full Annual Report (10-K). It contains the stand-alone audit report and audited financial statements, matching the “Audit Report / Information” category (AR).
2026-05-22 English
Intimation of record date for the purpose of payment of final dividend for FY 2025-26
Notice of Dividend Amount Classification · 90% confidence The document is an intimation to the stock exchange under Listing Regulations fixing the record date for determining shareholders entitled to the final dividend for year 2025-26. It does not contain full financial statements or governance rules, nor is it an earnings release or management report. This type of announcement falls under the ‘Notice of Dividend Amount’ category.
2026-05-22 English
Record Date
Notice of Dividend Amount Classification · 85% confidence The document is an official Listing Regulations disclosure to the stock exchange setting the record date for shareholders entitled to the final dividend. This is a shareholder dividend notice rather than a full financial report or other corporate action. It falls under “Notice of Dividend Amount” (DIV).
2026-05-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.